Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | IGLV6-57 | P01721 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | GHSR | Q92847 | 1/20 | 0.30 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29128593 | 0.89 | LDHA (0.31) | — | |
| SCHEMBL29128449 | 0.89 | MAPT (0.31) | — | |
| SCHEMBL29128309 | 0.86 | SLC6A4 (0.32) | — | |
| SCHEMBL29128439 | 0.86 | — | — | |
| SCHEMBL29128375 | 0.84 | MEN1 (0.34) | ALDH1A1MEN1KMT2A | |
| SCHEMBL29128268 | 0.83 | LMNA (0.31) | ALDH1A1KMT2AHSD17B10 | |
| SCHEMBL29128425 | 0.83 | MAPT (0.36) | ALDH1A1L3MBTL1NPSR1 | |
| SCHEMBL29128417 | 0.80 | — | — | |
| SCHEMBL29128243 | 0.79 | — | — | |
| SCHEMBL29125920 | 0.79 | ALDH1A1 (0.40) | ALDH1A1ADORA3ADORA2AADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117263862-A | Phenol-1, 3-oxazole/dihydroimidazole-2-ketone/thioketone compound and synthesis and application thereof | 吉首大学 | 2023-12-22 | — | — | CN | disclosed |